Alchemab Therapeutics
Phase 1Pioneering the next generation of antibody therapeutics for hard to treat diseases
Founded
2019
Focus
AntibodiesBiologics
About
Pioneering the next generation of antibody therapeutics for hard to treat diseases
Funding History
2Total raised: $92M
Series A$82MRA Capital ManagementSep 15, 2021
Seed$10MRA Capital ManagementOct 15, 2020
Company Info
TypePrivate
Founded2019
LocationCambridge, United Kingdom
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile